2021 NICE指南:成人静脉血栓栓塞

2021-08-19 英国国家卫生与临床优化研究所 NICE官网

该质量标准涵盖降低 16 岁及以上住院患者发生静脉血栓栓塞 (VTE) 的风险。它还包括诊断和治疗所有 18 岁及以上人群的 VTE。它描述了需要改进的优先领域的高质量护理。

中文标题:

2021 NICE指南:成人静脉血栓栓塞

英文标题:

Venous thromboembolism in adults

发布日期:

2021-08-19

简要介绍:

该质量标准涵盖降低 16 岁及以上住院患者发生静脉血栓栓塞 (VTE) 的风险。它还包括诊断和治疗所有 18 岁及以上人群的 VTE。它描述了需要改进的优先领域的高质量护理。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 NICE指南:成人静脉血栓栓塞.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3726a1c0022559da, title=2021 NICE指南:成人静脉血栓栓塞, enTitle=Venous thromboembolism in adults, guiderFrom=NICE官网, authorId=0, author=, summary=该质量标准涵盖降低 16 岁及以上住院患者发生静脉血栓栓塞 (VTE) 的风险。它还包括诊断和治疗所有 18 岁及以上人群的 VTE。它描述了需要改进的优先领域的高质量护理。, cover=https://img.medsci.cn/2021116/1636175756651_5579292.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence)是NHS的组织,设在伦敦和曼彻斯特。NICE成立于1999年4月1日,目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南,设定质量标准,管理国家数据库,为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Thu Aug 19 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #0e0e0e;">该质量标准涵盖降低 16 岁及以上住院患者发生静脉血栓栓塞 (VTE) 的风险。</span><span style="color: #0e0e0e;">它还包括诊断和治疗所有 18 岁及以上人群的 VTE。</span><span style="color: #0e0e0e;">它描述了需要改进的优先领域的高质量护理。</span></p>, tagList=[TagDto(tagId=3164, tagName=静脉血栓栓塞), TagDto(tagId=117835, tagName=静脉系统疾病)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=92, categoryName=血管外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3164, guiderKeyword=静脉血栓栓塞, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6261, appHits=936, showAppHits=0, pcHits=2145, showPcHits=5325, likes=3, shares=80, comments=30, approvalStatus=1, publishedTime=Tue Nov 16 23:57:01 CST 2021, publishedTimeString=2021-08-19, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Nov 06 13:48:19 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Fri Jan 05 15:49:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 NICE指南:成人静脉血栓栓塞.pdf)])
2021 NICE指南:成人静脉血栓栓塞.pdf
下载请点击:
评论区 (24)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1216480, encodeId=0a5e1216480d4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=330c8114473, createdName=ms6000000067978801, createdTime=Tue May 03 07:28:30 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214281, encodeId=ec161214281ae, content=<a href='/topic/show?id=28d6991e530' target=_blank style='color:#2F92EE;'>#静脉血栓#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99175, encryptionId=28d6991e530, topicName=静脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:27:24 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199441, encodeId=ea3611994410e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:42:45 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194957, encodeId=0bbf119495ea9, content=`有收益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Sat Feb 19 03:35:02 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186369, encodeId=d38911863699d, content=想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d7e6154734, createdName=ms8000000337320497, createdTime=Thu Jan 20 10:14:22 CST 2022, time=2022-01-20, status=1, ipAttribution=)]
    2022-05-03 ms6000000067978801

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1216480, encodeId=0a5e1216480d4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=330c8114473, createdName=ms6000000067978801, createdTime=Tue May 03 07:28:30 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214281, encodeId=ec161214281ae, content=<a href='/topic/show?id=28d6991e530' target=_blank style='color:#2F92EE;'>#静脉血栓#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99175, encryptionId=28d6991e530, topicName=静脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:27:24 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199441, encodeId=ea3611994410e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:42:45 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194957, encodeId=0bbf119495ea9, content=`有收益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Sat Feb 19 03:35:02 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186369, encodeId=d38911863699d, content=想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d7e6154734, createdName=ms8000000337320497, createdTime=Thu Jan 20 10:14:22 CST 2022, time=2022-01-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1216480, encodeId=0a5e1216480d4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=330c8114473, createdName=ms6000000067978801, createdTime=Tue May 03 07:28:30 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214281, encodeId=ec161214281ae, content=<a href='/topic/show?id=28d6991e530' target=_blank style='color:#2F92EE;'>#静脉血栓#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99175, encryptionId=28d6991e530, topicName=静脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:27:24 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199441, encodeId=ea3611994410e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:42:45 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194957, encodeId=0bbf119495ea9, content=`有收益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Sat Feb 19 03:35:02 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186369, encodeId=d38911863699d, content=想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d7e6154734, createdName=ms8000000337320497, createdTime=Thu Jan 20 10:14:22 CST 2022, time=2022-01-20, status=1, ipAttribution=)]
    2022-03-04 ms3000000452816472

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1216480, encodeId=0a5e1216480d4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=330c8114473, createdName=ms6000000067978801, createdTime=Tue May 03 07:28:30 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214281, encodeId=ec161214281ae, content=<a href='/topic/show?id=28d6991e530' target=_blank style='color:#2F92EE;'>#静脉血栓#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99175, encryptionId=28d6991e530, topicName=静脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:27:24 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199441, encodeId=ea3611994410e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:42:45 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194957, encodeId=0bbf119495ea9, content=`有收益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Sat Feb 19 03:35:02 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186369, encodeId=d38911863699d, content=想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d7e6154734, createdName=ms8000000337320497, createdTime=Thu Jan 20 10:14:22 CST 2022, time=2022-01-20, status=1, ipAttribution=)]
    2022-02-19 ms8000000374682656

    `有收益

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1216480, encodeId=0a5e1216480d4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=330c8114473, createdName=ms6000000067978801, createdTime=Tue May 03 07:28:30 CST 2022, time=2022-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1214281, encodeId=ec161214281ae, content=<a href='/topic/show?id=28d6991e530' target=_blank style='color:#2F92EE;'>#静脉血栓#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99175, encryptionId=28d6991e530, topicName=静脉血栓)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon Apr 25 22:27:24 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1199441, encodeId=ea3611994410e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a6d6534121, createdName=ms3000000452816472, createdTime=Fri Mar 04 17:42:45 CST 2022, time=2022-03-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194957, encodeId=0bbf119495ea9, content=`有收益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/1ac509b02e474a62b04821218d545591/41999e8f8740491a9831ef637a726745.jpg, createdBy=6c8a5450541, createdName=ms8000000374682656, createdTime=Sat Feb 19 03:35:02 CST 2022, time=2022-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1186369, encodeId=d38911863699d, content=想看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d7e6154734, createdName=ms8000000337320497, createdTime=Thu Jan 20 10:14:22 CST 2022, time=2022-01-20, status=1, ipAttribution=)]
    2022-01-20 ms8000000337320497

    想看

    0

拓展阅读

2015 APTA循证临床实践指南:静脉血栓栓塞高风险或确诊患者的管理中物理治疗师的作用

美国物理治疗协会(APTA,American Physical Therapy Association) · 2015-10-29

2015 中国肿瘤相关静脉血栓栓塞症预防与治疗专家指南

中国临床肿瘤学会(CSCO,Chinese Society of Clinical Oncology) · 2015-11-30

2016 EAST实践管理指南:儿童外伤患者静脉血栓栓塞的预防

美国东部创伤外科学会(EAST,The Eastern Association for the Surgery of Trauma) · 2016-12-23

2016 ESO指南:无活动能力急性缺血性卒中患者静脉血栓栓塞的预防

欧洲卒中组织(ESO,European Stroke Organisation) · 2016-03-01

2017 ESA指南:老年手术患者围术期静脉血栓栓塞预防

欧洲麻醉学会(ESA,European Society of Anaesthesiology) · 2017-09-09